BRIEF-Bellerophon Therapeutics says co terminated sales agreement - sec filing
May 2 Bellerophon Therapeutics Inc
* Bellerophon Therapeutics says effective April 26 , co terminated at market issuance sales agreement entered into on May 27, 2016 - SEC Filing
* Bellerophon Therapeutics Inc - Decided to terminate sales agreement because it does not intend to utilize sales agreement to raise additional capital Source text: [bit.ly/2pD4Fdy] Further company coverage: